Conor Duggan
University of Nottingham
158 Papers
1.2K Citations
Conor Duggan is an academic researcher from University of Nottingham. The author has contributed to research in topics: Personality & Personality disorders. The author has an hindex of 37, co-authored 153 publications. Previous affiliations of Conor Duggan include University of Leicester & Nottinghamshire Healthcare NHS Foundation Trust.
Chat about Author
Papers
Psychological therapies for people with borderline personality disorder
TL;DR: Assessment of the effects of psychological interventions for borderline personality disorder (BPD) found moderate to large statistically significant effects indicating a beneficial effect of DBT over TAU for anger.
Does treatment really make psychopaths worse? A review of the evidence.
TL;DR: It is concluded that the commonly held belief of an inverse relationship between high-scores on the PCL-R and treatment response has not been established.
263
Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial.
Navjot Bedi,C. E. D. Chilvers,Richard Churchill,Michael E. Dewey,Conor Duggan,Katherine Fielding,Virginia Gretton,Paul Miller,Glynn Harrison,Alan Lee,Idris Williams +10 more
TL;DR: A partially randomised preference trial to determine whether counselling is as effective as antidepressants for depression in primary care and whether allowing patients to choose their treatment affects their response, finding no differences in the baseline characteristics of the randomised and preference groups.
Psychological interventions for antisocial personality disorder
Simon Gibbon,Conor Duggan,Jutta Stoffers,Nick Huband,Birgit Völlm,Michael Ferriter,Klaus Lieb +6 more
TL;DR: The body of evidence summarised in this review is insufficient to allow any conclusion to be drawn about the use of pharmacological interventions in the treatment of antisocial personality disorder.
Pharmacological interventions for people with borderline personality disorder
TL;DR: Antipsychotics may effect some mental state symptoms more effectively than placebo but results are difficult to interpret clinically and there is little evidence of advantage of one antipsychotic over another.
177